- Home
- TCRX vs PRPL Comparison
TCRX vs PRPL Comparison
Compare TCRX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | PRPL |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 76.9M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TCRX | PRPL |
|---|---|---|
| Price | $1.11 | $0.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $7.00 | $0.65 |
| AVG Volume (30 Days) | ★ 937.1K | 497.6K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 152.75 |
| EPS | ★ N/A | N/A |
| Revenue | $10,325,000.00 | ★ $468,725,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | $19.81 | $6.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.88 | $0.41 |
| 52 Week High | $2.57 | $1.26 |
Technical Indicators
Market Signals| Indicator | TCRX | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 27.03 |
| Support Level | $0.93 | N/A |
| Resistance Level | $1.21 | $0.72 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 5.27 | 2.42 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.